// App-Quantinova.ai

e20713 : Duloxetine in symptomatic chemotherapy-induced peripheral neuropathy: Single-center experience beyond the clinical trial.

Researchers

Presenter

  • Roser Velasco

Principal Investigators

  • Cristina Santos

  • Roso Sala

  • Miguel J. Gil Gil

  • Laura Jimenez

  • Beatriz Pardo

  • Ma Carmen Galan

  • Ramon Palmero

  • Ramon Salazar

  • Jordi Bruna

  • Marta Simo

  • Cristina Izquierdo

Medical Centers

  • GEICO and IDIBELL, Institut Catal dOncologia, LHospitalet (Barcelona), Spain

  • Translational Research Laboratory and Department of Medical Oncology, Institut Catal dOncologia-IDIBELL, LHospitalet de Llobregat, SpainDeparment of Medical Oncology, Institut Catala Oncologia, IDIBELL, Hospitalet De Llobregat, SpainUniversity Hospital of Bellvitge, Barcelona, Spain

  • ICO Institut Catala d'Oncologia, Barcelona, Spain

  • Hospital Duran i Reynals, Institut Catal d Oncologia, L Hospitalet De Lobregat, Spain

  • Catalan Institute of Oncology, Section of Medical Oncology, LHospitalet de Llobregat, Spain

  • Medical Oncology Unit, Institut Catal dOncologia, LHospitalet, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Peripheral neuropathy

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Duloxetine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved